ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Oregon Health & Science University at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Oregon Health & Science University brings 13 presentations to ACR Convergence 2026 in Orlando. Its program centres on axial spondyloarthritis, including treatment guidelines, cardiovascular risk and chronic and nociplastic pain, with brain imaging and light sensitivity studies. It also covers Blau syndrome and NOD2 biology, and how climate and infections shape rheumatic disease.

OrganizationACR Convergence 2026 Attendance
Universities and research institutes
A public academic health center and research university.
Talk
Fri Nov 6
8:05am–9:00am
Part of Global Summit: Opening Session
Keynote: Infectious Triggers, Immune Consequences: Rheumatologic Disease in a Warming World
Virtual
Education and careers
Session
Fri Nov 6
1:00pm–1:55pm
Part of EscapeRheum
EscapeRheum
W415D
Education and careers · with Virginia Mason Franciscan Health, University of Michigan, University of Iowa +1 more
Session
Mon Nov 9
10:00am–11:30am
2026 ACR/SPARTAN/SAA Guidelines for the Treatment of Axial Spondyloarthritis (axSpA) and Juvenile Axial Spondyloarthritis (J-axSpA)
W415D
Spondyloarthritis and PsA · with University of California, San Francisco, Arthritis & Rheumatism Associates
  1. 10:00amGeneral Management Concepts and Review of Treatment Algorithms in axSpARocky Mountain Regional VA Medical Center
  2. 10:30amApplication of Guidelines for Treatment of Adults with axSpAOregon Health & Science University
  3. 11:00amAxial Spondyloarthritis and Juvenile Axial SpondyloarthritisUniversity of Alabama at Birmingham
Talk
Mon Nov 9
10:30am–11:00am
Part of 2026 ACR/SPARTAN/SAA Guidelines for the Treatment of Axial Spondyloarthritis (axSpA) and Juvenile Axial Spondyloarthritis (J-axSpA)
Application of Guidelines for Treatment of Adults with axSpA
W415D
Spondyloarthritis and PsA
Poster
Mon Nov 9
10:30am–12:30pm
Session
Tue Nov 10
8:00am–9:30am
A NOD '2' Change: A Model Gene Linking Inborn Errors of Immunity to Rheumatic Disease
W110A
Immunology · with University of Iowa, Washington University in St. Louis
  1. 8:00amA Novel Role for T Cell-Intrinsic NOD2 in Suppressing IL-17A and IL-17F Mediated Arthritis, Uveitis, and Blau SyndromeUniversity of Colorado Anschutz Medical Campus
  2. 8:30amAdult-Onset Autoinflammatory Disease Associated with NOD2 Risk VariantsMayo Clinic
  3. 9:00amPotential Immunogenetic Mechanisms Linking NOD2 Low-Penetrance or Risk Variants and Chronic DiseaseNational Human Genome Research Institute

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Oregon Health & Science University

Tell us what you sell and we’ll find the people at Oregon Health & Science University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction